Yueyang Hongfu Lin Biological Products Co., Ltd.



Yueyang Hongfulin Biological Products Co., Ltd. was established in 2019 and is a wholly-owned subsidiary of Yueyang New Huada Pharmaceutical Co., Ltd. The company focuses on the research and development of biological drugs, covering recombinant protein drugs, vaccines and virus detection and diagnostic kits. Among them, recombinant protein drugs include new interleukin-2, TNF, Mycobacterium intracellulare, vaccines include influenza vaccines and new coronavirus vaccines, and virus detection kits include antibody diagnosis and fluorescence quantitative PCR of new coronavirus.

 

The company has built a number of R & D platforms, including yeast expression system, mammalian cell expression system, insect-baculovirus expression platform, cell gene editing platform, inactivated virus vaccine platform, etc. The construction of various R & D platforms is becoming more and more perfect. The main supporting facilities and equipment include biosafety secondary laboratory, animal room, protein nucleic acid detection instrument, high performance liquid chromatography instrument, protein purification instrument, pilot fermentation tank, etc. The company has an excellent team, R & D team is full of vitality, the average age is less than 30 years old.

 

The company cooperates with Hunan Institute of Technology, China Center for Disease Control and other institutes, and employs a number of professors and experts as technical consultants. The company has achieved phased results in a number of projects under research, and two or three projects are about to submit applications for drug clinical trials.